Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

02. Dezember 2020 08:00 ET | Quelle: SteroTherapeutics

SteroTherapeutics, LLC signs CRADA Agreement with NIH to Develop a Novel Treatment for Cushing Syndrome Patients

SPRING HOUSE, Pa., Dec. 02, 2020 (GLOBE NEWSWIRE) -- SteroTherapeutics, LLC, a biopharmaceutical company developing new treatments for patients with rare diseases announced today the signing of a...
28. März 2019 07:30 ET | Quelle: SteroTherapeutics

SteroTherapeutics Receives New U.S. Patent for treatment of non-alcoholic Steatohepatitis (NASH)

PHILADELPHIA, March 28, 2019 (GLOBE NEWSWIRE) -- SteroTherapeutics, a privately held biopharmaceutical company developing therapies for metabolic diseases focused on non-alcoholic steatohepatitis...
04. April 2018 08:00 ET | Quelle: SteroTherapeutics

SteroTherapeutics Receives FDA Orphan-Drug Designation

PHILADELPHIA, April 04, 2018 (GLOBE NEWSWIRE) -- SteroTherapeutics, a privately held biopharmaceutical company developing therapies focused on metabolic diseases including non-alcoholic...
27. Februar 2018 10:52 ET | Quelle: SteroTherapeutics

SteroTherapeutics Announces Closing of Financing to Accelerate Clinical Study for Non-Alcoholic Steatohepatitis (NASH)

PHILADELPHIA, Feb. 27, 2018 (GLOBE NEWSWIRE) -- SteroTherapeutics, a privately held biopharmaceutical company developing metabolic-based therapies focused on non-alcoholic steatohepatitis (NASH),...